ONCOTELIC
Oncotelic Inc. operates as a cancer immunotherapy company. The Company engaged in developing a unique TGF-b antisense therapy which has demonstrated the ability to break immune tolerance in mid-stage clinical trials for the treatment of glioblastoma and pancreatic cancer. Oncotelic serves customers in the United States.
ONCOTELIC
Industry:
Clinical Trials Pharmaceutical Therapeutics
Address:
Agoura Hills, California, United States
Country:
United States
Website Url:
http://www.oncotelic.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache Wordpress Plugins
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Current Employees Featured
Vuong Trieu CEO @ Oncotelic
CEO
Fatih Uckun CMO @ Oncotelic
CMO
2022-05-01
Chulho Park CBO & Co-Founder @ Oncotelic
CBO & Co-Founder
2015-01-01
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-03 | Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as Chief Medical Officer |
Official Site Inspections
http://www.oncotelic.com
- Host name: biz267.inmotionhosting.com
- IP address: 23.235.222.9
- Location: El Segundo United States
- Latitude: 33.9214
- Longitude: -118.413
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90245
More informations about "Oncotelic"
About Us - Oncotelic
Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, the lead immuno-oncology drug candidate of …See details»
Oncotelic - Crunchbase Company Profile & Funding
Oncotelic is an immuno-oncology company developing RNA therapeutics and small molecule drugs against cancer and infectious diseases. It seeks to leverage its deep expertise in drug development to improve treatment outcomes and …See details»
Oncotelic - Crunchbase Company Profile & Funding
Oncotelic Inc. operates as a cancer immunotherapy company. The Company engaged in developing a unique TGF-b antisense therapy which has demonstrated the ability to break …See details»
Investor Overview - Oncotelic
Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, …See details»
Oncotelic, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Oncotelic, Inc. with its drug pipeline, therapeutic area, technology platform, 19 news, and 12 literature, Disease Domain:Endocrinology and Metabolic Disease ...See details»
OncoTelic Company Profile 2024: Stock Performance & Earnings
OncoTelic General Information Description. Oncotelic Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing drugs for the treatment of orphan …See details»
Oncotelic Therapeutics Company Description - Stock Analysis
Nov 7, 2024 Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. It develops OXi4503 for …See details»
Oncotelic Therapeutics, Inc. Company Profile - Dun & Bradstreet
Doing Business As: Oncotelic. Company Description: Mateon Therapeutics (formerly OXiGENE) is a biopharmaceutical company focused on vascular targeted therapy in oncology, which …See details»
Oncotelic - Contacts, Employees, Board Members, Advisors
Oncotelic is an immuno-oncology company developing RNA therapeutics and small molecule drugs against cancer and infectious diseases.See details»
Oncotelic - Overview, News & Similar companies | ZoomInfo.com
Mar 4, 2024 Oncotelic. Business Services · California, United States · <25 Employees. View Company Info for Free. About. Headquarters 29397 Agoura Rd Ste 107, Agoura Hills, …See details»
A TGF-beta Company - Oncotelic
Oct 26, 2021 Oncotelic C001-2020-01 IM Presentation 10. WWW.ONCOTELIC.COM Vascular Distruptor Agent (VDA) OXi4503: Mechanism-of-Action in AML • Phase 1B study was to define …See details»
Oncotelic Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Oncotelic is seeking to leverage its deep expertise in oncology drug development to improve treatment outcomes and survival of cancer patients with a special emphasis on rare pediatric …See details»
Oncotelic Company Overview, Contact Details & Competitors
Mar 26, 2010 Oncotelic. Biotechnology Research California, United States 11-50 Employees. Oncotelic /Mateon is a convergent of PointR AI clustercomputing, Oncotelic antisense …See details»
Oncotelic - Contacts, Employees, Board Members, Advisors
Oncotelic is a cancer immunotherapy company. Unlock even more features with Crunchbase ProSee details»
ONCOTELIC PRESENTATION AT PRECISION IN DRUG DISCOVERY …
Oct 23, 2024 Oncotelic (f/k/a Mateon Therapeutics, Inc.), was formed in the State of New York in 1988 as OXiGENE, Inc., was reincorporated in the State of Delaware in 1992, and changed its …See details»
Oncotelic Therapeutics Implements PDAOAI Platform | OTLC
2 days ago The platform will be governed through our decentralized autonomous organization (DAO), Pet2DAO, using the PDAO token. This decentralized structure ensures transparent …See details»
Contact - Oncotelic
Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious diseases. OT-101, …See details»
Oncotelic Therapeutics Implements PDAOAI Platform
1 day ago About Oncotelic. Oncotelic (f/k/a Mateon Therapeutics, Inc.), was formed in the State of New York in 1988 as OXiGENE, Inc., was reincorporated in the State of Delaware in 1992, …See details»
A TGF-beta Company - Oncotelic
Jan 26, 2022 Oncotelic C001-2020-01 IM Presentation 10. A Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study of OT-101 in Hospitalized COVID-19 Subjects • …See details»
Press Releases - Oncotelic
Jul 29, 2024 Oncotelic is an immuno-oncology company dedicated to the development of first in class RNA therapeutics as well as small molecule drugs against cancer and infectious …See details»